You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. STTR Phase I: Protease-based purification of recombinant human matrix metalloproteases

    SBC: Sarkar-Klein-Labs            Topic: BT

    The broader impact of this Small Business Technology Transfer (STTR) Phase I project is an enabling technology to improve research into many diseases. This STTR project will develop human matrix metalloprotease (MMPs), a class of enzymes that degrade many biomolecules including collagen, the most abundant structural protein in the human body. MMPs are critical for numerous normal and pathological ...

    STTR Phase I 2021 National Science Foundation
  2. STTR Phase I: Design and development of novel oral drug formulations by leveraging the food effect

    SBC: MECHASIM INC.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is the development of novel food-based oral dosage forms of pharmaceutics potentially superior to traditional tablets as they can be administered at lower doses without compromising therapeutic benefits. Currently tablet form preparations require administration at high doses to achieve desired ...

    STTR Phase I 2021 National Science Foundation
  3. STTR Phase I: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)

    SBC: THINK BIOSCIENCE, INC.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase 1 project is to develop new lead compounds for treating COVID-19 by using microbial systems. The microbial assembly approach, which enables rapid, fermentation-based scale-up of therapeutic candidates for pre-clinical studies and early human trials, could accelerate the pace and reduce the cost of thera ...

    STTR Phase I 2021 National Science Foundation
  4. STTR Phase I: Development of a Three Dimensional Paver

    SBC: SUSTAINABLE ROAD ENGINEERING INC.            Topic: R

    The broader impact/commercial potential of this innovation is significant. The US has more than 3 million miles of paved roads. Roughly 3.5% of the network is repaved annually using a free-floating screed invented in 1930. In the past 5 years, the paving industry in the US generated an average annual revenue of $25 billion. 3D paving lends itself to many possibilities, including correcting surface ...

    STTR Phase I 2021 National Science Foundation
  5. STTR Phase I: Feasibility Study of Chip-Scale Iodine Vapor Cell Fabrication

    SBC: VAPOR CELL TECHNOLOGIES LLC            Topic: IH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve measurement science. Currently, special low-pressure chambers known as "vapor cells" are made by hand in a select number of precision glassblowing shops and suffer from poor dimensional reproducibility, low production capacity, irregular sizes, and variable vapor composition lead ...

    STTR Phase I 2021 National Science Foundation
  6. STTR Phase I: A platform for the rapid discovery of human antibodies as therapeutics for infectious disease (COVID-19)

    SBC: Altigg Therapeutics, Inc.            Topic: PT

    The broader impacts of this Small Business Technology Transfer (STTR) Phase I project are to establish a novel and rapid drug-discovery platform aimed at infectious diseases. An opportunity is to tap into an unexplored diversity of human antibodies and develop them into therapies. This technology aims to identify drug candidates and select therapeutic candidates quickly. The established platform w ...

    STTR Phase I 2021 National Science Foundation
  7. STTR Phase I: A Software Platform for Assessment of Untrusted Electronics

    SBC: SILICON ASSURANCE LLC            Topic: S

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to address the security challenges that currently exist in integrated circuit (IC) design and the electronic design automation (EDA) software market. It will create a platform for ‘secure-by-design' of integrated circuits using untrusted third-party intellectual property blocks. It will p ...

    STTR Phase I 2021 National Science Foundation
  8. STTR Phase I:Dramatically improving algorithm execution on quantum devices through advanced noise-awareness and control

    SBC: Aliro Technologies, Inc.            Topic: QT

    The broader impact of this Small Business Technology Transfer (STTR) Phase I project will be to enable much more widespread use of quantum computing. Quantum computing will drive massive improvements in the world economy and the human condition in areas as diverse as drug discovery, novel materials, energy efficiency, and artificial intelligence. Industry analysts project rapid growth for the quan ...

    STTR Phase I 2021 National Science Foundation
  9. STTR Phase I: Near Infrared Nerve-Specific Fluorophores for Fluorescence-Guided Surgery

    SBC: INHERENT TARGETING LLC            Topic: BT

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is the development of a technology that will reduce intraoperative nerve damage using fluorescence imaging to enable surgeons to see the unseen. Intraoperative nerve injury is a major complication of surgery, affecting all specialties and often causing irreparable damage. Nerve damage occurs in ~17% of all surgeri ...

    STTR Phase I 2021 National Science Foundation
  10. STTR Phase I: Structure Property Relationship Studies for Designing Next Generation Nanocomposite Blood Bags

    SBC: Xheme Inc.            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project addresses the degradation, waste and shortage of stored blood. This project proposes a blood bag capable of preserving the overall health and vigor of stored blood, including rare blood types, and extending the shelf life of blood and platelets. Donated blood begins to degrade on day 11 and ex ...

    STTR Phase I 2021 National Science Foundation
US Flag An Official Website of the United States Government